Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Enovis Corporation Common Stock
(NY:
ENOV
)
22.64
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Apr 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Enovis Corporation Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
ENOV Stock Earnings: Enovis Beats EPS, Misses Revenue for Q2 2024
↗
August 07, 2024
ENOV stock results show that Enovis beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Enovis Announces Second Quarter 2024 Results
August 07, 2024
From
Enovis Corporation
Via
GlobeNewswire
Enovis Announces Time Change for Second Quarter 2024 Results Conference Call
July 25, 2024
From
Enovis Corporation
Via
GlobeNewswire
Enovis to Host Second Quarter 2024 Results Conference Call on August 7th
July 16, 2024
From
Enovis Corporation
Via
GlobeNewswire
Critical Insights From Enovis Analyst Ratings: What You Need To Know
↗
July 02, 2024
Via
Benzinga
A Closer Look at 6 Analyst Recommendations For Enovis
↗
May 03, 2024
Via
Benzinga
Earnings Outlook For Enovis
↗
February 21, 2024
Via
Benzinga
Enovis™ Releases AltiVate Reverse® Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse®
July 12, 2024
New full-range solution adds bone-sparing baseplate, peripheral fixation, and glenosphere options to proven reverse shoulder prosthesis (RSP®) glenoid baseplate while maintaining hallmark simplicity...
From
Enovis Corporation
Via
GlobeNewswire
Top 3 Health Care Stocks That Could Blast Off In June
↗
June 21, 2024
Via
Benzinga
5 Medical Info Systems Stocks To Buy For Stable Returns
↗
May 11, 2024
The medical info systems industry is thriving due to the growing demand for contactless services. Amid this environment, here are some stocks in the industry that may see stable returns in 2024.
Via
Talk Markets
Enovis to Participate in Upcoming Investor Conferences
May 10, 2024
From
Enovis Corporation
Via
GlobeNewswire
5 Analysts Have This To Say About Enovis
↗
February 13, 2024
Via
Benzinga
The Analyst Landscape: 6 Takes On Enovis
↗
January 08, 2024
Via
Benzinga
Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month
↗
May 07, 2024
Via
Benzinga
ENOV Stock Earnings: Enovis Beats EPS, Beats Revenue for Q1 2024
↗
May 02, 2024
ENOV stock results show that Enovis beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Enovis Announces First Quarter 2024 Results
May 02, 2024
From
Enovis Corporation
Via
GlobeNewswire
Enovis to Host First Quarter 2024 Results Conference Call on May 2nd
April 17, 2024
From
Enovis Corporation
Via
GlobeNewswire
Analyst Ratings for Enovis
↗
December 15, 2023
Via
Benzinga
Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Conference
March 28, 2024
From
Enovis Corporation
Via
GlobeNewswire
Medtech Firm Enovis Sets Strong 2024 Targets As Q4 Earnings Beat Expectations, Analyst Says Growth Intact
↗
February 22, 2024
Enovis reports Q4 results with net sales surging 11% YoY, reaching $455 million. The growth is attributed to strong performance in P&R and above-market expansion in Recon, coupled with recent...
Via
Benzinga
Topics
Earnings
Enovis Announces Fourth Quarter and Full Year 2023 Results
February 22, 2024
From
Enovis Corporation
Via
GlobeNewswire
Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting
February 12, 2024
From
Enovis Corporation
Via
GlobeNewswire
Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
February 07, 2024
From
Enovis Corporation
Via
GlobeNewswire
Enovis Showcases New Foot & Ankle Offerings at the ACFAS Annual Meeting
January 29, 2024
New solutions in Percutaneous and Open Bunion procedures, External Fixation, and STAR® Ankle will be featured as part of the company’s growing evidence-based, innovative portfolio.
From
Enovis Corporation
Via
GlobeNewswire
Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd
January 26, 2024
From
Enovis Corporation
Via
GlobeNewswire
Enovis Introduces the DonJoy ROAM™ OA Knee Brace
January 25, 2024
The newest innovation in unloader braces is comfortable, easy to use and effective.
From
Enovis Corporation
Via
GlobeNewswire
This Analyst Sees Durable Share Gains, Margin Expansion For Orthopedics-Focused Enovis
↗
January 03, 2024
William Bliar has initiated coverage on Enovis Corp (NYSE: ENOV), a medical technology company focusing on the orthopedics market valued at approximately $25 billion, experiencing steady growth,...
Via
Benzinga
Enovis Completes Acquisition of LimaCorporate S.p.A
January 03, 2024
From
Enovis Corporation
Via
GlobeNewswire
Enovis to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
December 28, 2023
From
Enovis Corporation
Via
GlobeNewswire
This Analyst Selects Enovis As Top Pick For 2024: Spotlight On EMPOWR Revision Launch
↗
December 15, 2023
Needham analyst Mike Matson reiterated the Buy rating on Enovis Corporation (NYSE: ENOV), raising
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today